Drug Shortage Report for DEXAMETHASONE SODIUM PHOSPHATE INJECTION, USP

Last updated on 2019-10-01 History
Report ID 94226
Drug Identification Number 01977547
Brand name DEXAMETHASONE SODIUM PHOSPHATE INJECTION, USP
Common or Proper name DEXAMETHASONE SODIUM PHOSPHATE INJECTION USP
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) DEXAMETHASONE PHOSPHATE
Strength(s) 4MG
Dosage form(s) LIQUID
Route of administration INTRA-ARTICULAR INTRAMUSCULAR INTRAVENOUS
Packaging size 1 VIAL
ATC code H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2019-09-18
Estimated end date 2019-10-01
Actual end date 2019-09-30
Shortage status Resolved
Updated date 2019-10-01
Company comments Stock is available at McKesson.
Health Canada comments
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2019-10-01 English Compare
v5 2019-09-30 French Compare
v4 2019-09-30 English Compare
v3 2019-09-19 English Compare
v2 2019-09-18 French Compare
v1 2019-09-18 English Compare